May 14, 2026
Tirzepatide GLP-1 GIP: Dual Agonist Preclinical Research
Explore preclinical Tirzepatide GLP-1 GIP dual agonist research: receptor mechanisms, SURPASS data context, metabolic effects vs semaglutide and retatrutide.
RESEARCH NOTES
Research.
Read →
May 6, 2026
Oral Peptides Metabolic Effects in Animal Models 2026
Explore 2026 preclinical research on oral peptides metabolic effects — GLP-1, BPC-157, MOTS-c, and NAD+ data from rodent animal model studies reviewed here.
May 6, 2026
Oral GLP-1 Appetite Regulation: Preclinical Animal Data
Explore preclinical animal model data on oral GLP-1 appetite regulation, covering food intake, satiety hormones, and hypothalamic GLP-1R activation research.
May 6, 2026
BPC-157 and GLP-1 in Longevity Research: Key Findings
BPC-157 and GLP-1 longevity research: overlapping mechanisms in metabolic health, cellular repair, mitochondrial function and preclinical anti-aging data.
May 6, 2026
GLP-1 Research vs Oral Semaglutide: Preclinical Data
GLP-1 research compounds vs oral semaglutide: preclinical mechanism comparison, bioavailability data, and what laboratory models show about each compound class.
May 6, 2026
Oral GLP-1 Analogs: Delivery Challenges for Research
Oral GLP-1 analogs delivery challenges: preclinical pharmacokinetics, degradation barriers, formulation strategies and 2026 research compound comparison data.
May 5, 2026
GLP-1 Peptides for Research: Retatrutide and Orals
GLP-1 research compounds explained: native GLP-1, Retatrutide, and Orforglipron. Mechanisms, research applications, and oral capsule delivery. COA verified.